CIK 0001129928
- Non-accelerated filer
- Smaller reporting company
ONCOLYTICS BIOTECH INC
Sign in to watch- Ticker
- ONCY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980541667
- Phone
- +1 403-670-7377
- Business address
- SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- 4 Open-market buy Director bought 30,000 shares at $0.84 ($25,338)
- 4 Open-market buy Chief Medical Officer bought 12,132 shares at $0.83 ($10,033)
- 4 Open-market buy Director bought 25,000 shares at $0.85 ($21,240)
- 4 Open-market buy VP, Product Development bought 10,000 shares at $0.83 ($8,298)
- 4 Open-market buy Director bought 100,000 shares at an average $0.83 ($83,454)
- 4 Open-market buy Chief Business Officer bought 29,600 shares at $0.86 ($25,418)
- 4 Open-market buy Director bought 35,400 shares at $0.86 ($30,292)
- 4 Open-market buy Director bought 100,000 shares at $1.04 ($103,770)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 2 · 40 filings